News
Looking at licensing deals struck in the past 10 years, Jefferies found that many Big Pharmas do not ultimately follow ...
MRT-8102, a highly selective NEK7-directed molecular glue degrader (MGD) developed to treat inflammatory conditions linked to NLRP3, IL-1β, and IL-6 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback